
Natalie Aleksić is a PhD candidate in Business Administration at the Stockholm School of Economics, House of Innovation. Her research explores how Artificial Intelligence transforms innovation and performance, with a particular focus on the life sciences and pharmaceutical drug discovery. She is an affiliated PhD within WASP–HS, the Wallenberg Foundation’s program on AI, autonomous systems, software program – humanity and society, and holds a master’s degree with distinction from KTH Royal Institute of Technology.